OpenAI’s Wild Week: Custom Chips, DRAM Share, Cold Bet
OpenAI accelerates its shift from software to silicon and bio bets, unveiling a custom chip, a DRAM stake, and a majo...
Tackling unexpected financial costs starts with a clear plan and small, steady changes you can implement today.
24,369 articlesOpenAI accelerates its shift from software to silicon and bio bets, unveiling a custom chip, a DRAM stake, and a majo...
In a wave of filings, multiple lawsuits claim hometap mischaracterized its HEI agreements and breached TILA, intensif...
ASML’s price sits near the $1,800 mark, sparking questions about a possible stock split. This guide explains what a s...
The GLP-1 wave has traders buzzing. While Lilly and Novo Nordisk hold steady as reliable bets, smart portfolios tap i...
Wall Street is piling into hydration brands as 'functional hydration' takes hold. The trend follows social media chat...
Adobe’s chief marketing officer is steering a bold pivot to AI-powered brand discovery, reshaping budgets, metrics, a...
EU DAC8 and UK CARF rules are now driving tax reporting for 2027. As providers capture 2026 activity, investors shoul...
As quantum dreams grow from labs to law and logistics, Rigetti's domestic footprint and government ties could propel ...
When kevin warsh's inflation testimony landed, traders priced an 86% chance of a Fed rate hold. This article breaks d...
A growing cohort of self-custody Bitcoin holders now rides a steep unrealized-loss trail, while ETFs trimming exposur...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Young shoppers are driving a tangible-media surge, lifting vinyl and print book sales in the U.S. and U.K. while rede...